Tower Research Capital (TRC)’s iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038 JJS Stock Holding History

Tower Research Capital (TRC)’s Portfolio JJS Stock Details JJS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-38	Closed	-$2K	–	4804
2016 Q3	$2K	Buy	+38	New	+$1.58K	﹤0.01%	3201

Other funds holding JJS

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s JJS Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038 (JJS) in Q4 2016, closing a stake of 38 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in JJS in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 5 funds tracked by Wall St. Rank hold JJS as of Q4 2016.

Tower Research Capital (TRC) reported no remaining iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038 position as of Q4 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 38 iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038 shares in Q4 2016, an estimated $2K.
Tower Research Capital (TRC) first reported a position in iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038 in Q3 2016 and held it in 1 quarter.
Tower Research Capital (TRC)'s iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038 position peaked at $2K in Q3 2016.
5 funds tracked by Wall St. Rank held iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038 as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.